<?xml version="1.0" ?>
<document id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5">
  <chunk id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c0" text="Knock out of the BASIGIN/CD147 chaperone of lactate/H + symporters disproves its pro-tumour action via extracellular matrix metalloproteases (MMPs) induction">
    <entity charOffset="103-116" id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c0.e0" ontology_id="GO_0005576" text="extracellular" type="gene_function"/>
    <entity charOffset="103-123" id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c0.e1" ontology_id="GO_0031012" text="extracellular matrix" type="gene_function"/>
  </chunk>
  <chunk id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1" text="BASIGIN/CD147/EMMPRIN is a multifunctional transmembrane glycoprotein strongly expressed in tumours. BASIGIN controls tumour metabolism, particularly glycolysis by facilitating lactic acid export through the two monocarboxylate transporters MCT1 and hypoxia-inducible MCT4. However, before being recognized as a co-carrier of MCTs, BASIGIN was described as an inducer of extracellular matrix metalloproteases (MMPs). Early on, a model emerged in which, tumour cells use the extracellular domain of BASIGIN to recognize and stimulate neighbouring fibroblasts to produce MMPs. However, this model has remained hypothetical since a direct link between BASIGIN and MMPs production has not yet been clearly established. To validate the BASIGIN/MMP hypothesis, we developed BASIGIN knockouts in three human tumour cell lines derived from glioma, colon, and lung adenocarcinoma. By">
    <entity charOffset="43-56" id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e0" ontology_id="GO_0016021" text="transmembrane" type="gene_function"/>
    <entity charOffset="118-124" id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e1" ontology_id="HP_0002664" text="tumour" type="phenotype"/>
    <entity charOffset="150-160" id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e2" ontology_id="GO_0006096" text="glycolysis" type="gene_function"/>
    <entity charOffset="371-384" id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e3" ontology_id="GO_0005576" text="extracellular" type="gene_function"/>
    <entity charOffset="371-391" id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e4" ontology_id="GO_0031012" text="extracellular matrix" type="gene_function"/>
    <entity charOffset="453-459" id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e5" ontology_id="HP_0002664" text="tumour" type="phenotype"/>
    <entity charOffset="474-487" id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e6" ontology_id="GO_0005576" text="extracellular" type="gene_function"/>
    <entity charOffset="801-807" id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e7" ontology_id="HP_0002664" text="tumour" type="phenotype"/>
    <pair e1="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e0" e2="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e1" id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.p0" relation="true"/>
    <pair e1="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e0" e2="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e5" id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.p1" relation="true"/>
    <pair e1="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e0" e2="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e7" id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.p2" relation="true"/>
    <pair e1="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e1" e2="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e2" id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.p3" relation="true"/>
    <pair e1="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e1" e2="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e3" id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.p4" relation="true"/>
    <pair e1="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e1" e2="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e4" id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.p5" relation="true"/>
    <pair e1="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e1" e2="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e6" id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.p6" relation="true"/>
    <pair e1="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e2" e2="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e5" id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.p7" relation="true"/>
    <pair e1="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e2" e2="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e7" id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.p8" relation="true"/>
    <pair e1="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e3" e2="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e5" id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.p9" relation="true"/>
    <pair e1="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e3" e2="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e7" id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.p10" relation="true"/>
    <pair e1="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e4" e2="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e5" id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.p11" relation="true"/>
    <pair e1="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e4" e2="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e7" id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.p12" relation="true"/>
    <pair e1="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e5" e2="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e6" id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.p13" relation="true"/>
    <pair e1="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e6" e2="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.e7" id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c1.p14" relation="true"/>
  </chunk>
  <chunk id="26e8ef0fab0bc606adadae018a73d8490c8e1cd5.c2" text="Our findings do not support the notion that the pro-tumoural action of BASIGIN is mediated via induction of MMPs. Therefore, we propose that to date, the strongest pro-tumoural action of BASIGIN is mediated through the control of fermentative glycolysis."/>
</document>
